- $3.95m
- -$10.22m
- 14
- 55
- 14
- 16
Annual income statement for Galecto, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 33.6 | 52.2 | 61.2 | 39.9 | 22.3 |
| Operating Profit | -33.6 | -52.2 | -61.2 | -39.9 | -22.3 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -34.8 | -51.8 | -61.6 | -38.3 | -21.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -34.8 | -51.8 | -61.6 | -38.3 | -21.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -34.8 | -51.8 | -61.6 | -38.3 | -21.4 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -34.8 | -51.8 | -61.6 | -38.3 | -21.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -34.5 | -51.2 | -60.6 | -32.9 | -14.2 |